Your browser doesn't support javascript.
loading
Mouth opening in systemic sclerosis: A longitudinal analysis from the French National Cohort Study.
Chaigne, Benjamin; Bense, Alexandre; Agard, Christian; Allanore, Yannick; Pugnet, Grégory; Hachulla, Eric; Avouac, Jérôme; Bienvenu, Boris; Palat, Sylvain; Grange, Claire; Berthier, Sabine; Chatelus, Emmanuel; Rivière, Sébastien; Truchetet, Marie-Elise; Kahn, Jean-Emmanuel; Maurier, Francois; Diot, Elisabeth; Berezne, Alice; Mouthon, Luc.
Afiliação
  • Chaigne B; Service de Médecine Interne, Centre de Référence Maladies Autoimmunes Systémiques Rares d'Ile de France, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP), Ile de France, France.
  • Bense A; APHP-CUP, Hôpital Cochin, F-75014 Paris, Université Paris Cité, France.
  • Agard C; Service de Médecine Interne, Centre de Référence Maladies Autoimmunes Systémiques Rares d'Ile de France, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP), Ile de France, France.
  • Allanore Y; APHP-CUP, Hôpital Cochin, F-75014 Paris, Université Paris Cité, France.
  • Pugnet G; CHU Nantes, Service de Médecine interne, Nantes Université, Nantes, France.
  • Hachulla E; Rheumatology Department, Cochin hospital, Paris Cité University, Paris, France.
  • Avouac J; Centre Hospitalier Universitaire, Medecine Interne, Toulouse, France.
  • Bienvenu B; Université de Lille, INSERM, CHU Lille, Service de Médecine Interne et Immunologie Clinique, Centre de Référence des Maladies Autoimmunes Systémiques Rares Du Nord et Nord-Ouest de France, France.
  • Palat S; Rheumatology Department, Cochin hospital, Paris Cité University, Paris, France.
  • Grange C; Service de Médecine Interne, Centre Hospitalier National Ophtalmologique des 15-20, Paris.
  • Berthier S; CHU Limoges, Limoges, Limousin, France.
  • Chatelus E; Department of Internal Medicine, Lyon Sud University Hospital, Lyon, France.
  • Rivière S; Department of internal medicine, University hospital of Dijon, Dijon, France.
  • Truchetet ME; Rheumatology, Hôpitaux universitaires de Strasbourg, Strasbourg, France.
  • Kahn JE; Service de Médecine Interne and Inflammation-Immunopathology, Biotherapy Department (DMU 3iD), Sorbonne Université, Hôpital Saint-Antoine, AP-HP, Paris, 75012, France.
  • Maurier F; Rheumatology Department, University Hospital of Bordeaux, Centre de Référence des Maladies Autoimmunes Systémiques Rares Du Sud-Ouest, Bordeaux, France.
  • Diot E; Department of Internal Medicine, Hôpital Ambroise-Paré, Boulogne-Billancourt, France.
  • Berezne A; Department of Internal Medicine and Clinical Immunology, Hôpital Robert Schuman, Metz-Vantoux, 57070, France.
  • Mouthon L; Department of Internal Medicine and Clinical Immunology, University Hospital of Tours, Tours, France.
J Intern Med ; 2023 Jun 27.
Article em En | MEDLINE | ID: mdl-37376708
ABSTRACT

BACKGROUND:

Few studies have evaluated mouth opening (MO) in systemic sclerosis (SSc). None have studied MO trajectories.

OBJECTIVE:

To study MO trajectories in SSc.

METHODS:

This multicentre study included patients enrolled in the French national SSc cohort with at least one MO assessment, described patients based on MO baseline measure, modeled MO trajectories, and associated MO measures with SSc prognosis.

RESULTS:

We included 1101 patients. Baseline MO was associated with disease severity. On Kaplan-Meier analysis, MO < 30 mm was associated with worse 30-year-survival (p<0.01) and risk of pulmonary arterial hypertension (p<0.05). Individual MO trajectories were heterogenous among patients. The best model of MO trajectories according to latent-process mixed modeling showed that 88.8% patients had a stable MO trajectory and clustered patients into 3 groups that predicted SSc survival (p<0.05) and interstitial lung disease (ILD) occurrence (p<0.05). The model highlighted a cluster of 9.5% patients with diffuse cutaneous SSc (dcSSc) (p<0.05) and high but decreasing MO over 1 year (p<0.0001) who were at increased risk of poor survival and ILD.

CONCLUSION:

MO, which is a simple and reliable measure, could be used to predict disease severity and survival in SSc. Although MO remained stable in most SSc patients, dcSSc patients with high but decreasing MO were at risk of poor survival and ILD. This article is protected by copyright. All rights reserved.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Intern Med Assunto da revista: MEDICINA INTERNA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Intern Med Assunto da revista: MEDICINA INTERNA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França